United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension

NDA FilingRalinepagPositive

AI Analysis

Summary

United Therapeutics announced FDA acceptance of its New Drug Application for Ralinepag to treat pulmonary arterial hypertension. The acceptance marks a significant step forward in the regulatory pathway for the drug candidate.

Outcome Details

FDA accepted New Drug Application

Importance:7/10

Sentiment:

0.70

FDANDARalinepagPAHregulatory

Related Companies

$UTHR

Read the original article

Published by Drugs.com New Drug Applications on August 24, 2026 5:08 AM

Read Original